Artrya Limited operates as a medical technology company that uses artificial intelligence (AI) to identify patients at risk of coronary artery disease. It offers Salix, a cloud-based software that uses its AI to automate the detection of coronary artery disease from coronary computed tomography angiography. Artrya Limited was incorporated in 2018 and is based in West Perth, Australia.
| Market Capitalization | $16.5163 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | 0 |
| Book Value | 0.389 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.14 |
| EBITDA | -11,047 |
| Profit Margin | 0 |
| Operating Margin TTM | -11.492 |
| Return on Assets TTM | -0.1859 |
| Return on Equity TTM | -0.3128 |
| Revenue TTM | 996 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2019-06-30 | 0 | |||
| 2020-06-30 | 0 | |||
| 2021-06-30 | 0 | |||
| 2022-06-30 | 0 | 16,785 | ||
| 2023-06-30 | 0 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2019-06-30 | 910.08 | 914.54 | 61.57 | 0 | 1,000 | |
| 2020-06-30 | 2,228.93 | 2,655.24 | 162.39 | 0 | 3,977.004 | |
| 2021-06-30 | 50,126 | 52,218 | 1,170 | 37 | 55,798 | |
| 2022-06-30 | 15,285 | 43,869 | 3,229 | 220 | 56,398 | |
| 2023-06-30 | 20,132 | 33,088 | 2,532 | 0 | 56,435 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2019-06-30 | -146 | -96 | 1,318.852 | |||
| 2020-06-30 | -1,353.895 | -1,623.012 | 1,318.852 | |||
| 2021-06-30 | -4,080 | -1,487 | 10,754 | 12,982 | ||
| 2022-06-30 | -17,155 | -9,651 | 2,303 | 12,982 | 15,285 | |
| 2023-06-30 | -11,136 | -11,185 | 4,847 | 15,285 | 20,132 |